The reassessed potential of SARS-CoV-2 attenuation for COVID-19 vaccine development: a systematic review
This article was originally published here Virus. May 7, 2022; 14 (5): 991. doi: 10.3390 / v14050991. SUMMARY Live attenuated SARS-CoV-2 vaccines received relatively little attention during the COVID-19 pandemic. However, several methods are known to obtain attenuated coronaviruses. In this systematic review, coronavirus attenuation strategies were identified, which could potentially be applied to SARS-CoV-2. …